MENU
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2026 All rights reserved. Tickeron Inc.
RVNC
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Revance Therapeutics (RVNC) Ownership - Who owns Revance Therapeutics?

Revance Therapeutics Inc is a biotechnology company focused on aesthetic and therapeutic offerings, including its neuromodulator product, DaxibotulinumtoxinA for Injection... Show more

#MovingAverage#Momentum#MACD#Pattern#RSI#Stochastic#Aroon#Bollinger

Profile

Industry
Pharmaceuticals Other
Address
1222 Demonbreun Street
Phone
+1 615 724-7755
Employees
597
Web
https://www.revance.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
381.02M
P/E Ratio
N/A
Total Cash
184.08M
Projected Growth
N/A
Total Debt
483.45M
Revenue
256.95M
Risk (Beta)
0.76
Dividend Yield
N/A
Total Cash/Share
1.76
Total Debt/Equity
N/A
Revenue/Share
2.66 USD as % of share price
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
View AI-Driven Trading for RVNC
A.I. Advisor
published General Information

General Information

a developer of drugs

Industry Biotechnology

Profile
Details
Industry
Pharmaceuticals Other
Address
1222 Demonbreun Street
Phone
+1 615 724-7755
Employees
597
Web
https://www.revance.com